Murine erythroleukaemia cells (Friend cells) possess high-affinity binding sites for erythropoietin  by Mayeux, P. et al.
Volume 211, number 2, 229-233 FEB 04404 January 1987 
Murine erythroleukaemia cells (Friend cells) possess 
high-affinity binding sites for erythropoietin 
P. Mayeux, C. Billat and R. Jacquot 
Laboratoire de Physioiogie Animale, UFR aks Sciences Exactes et Naturelies, BP 347,51062 Reims Ckdex, France 
Received 12 November 1986 
Murine erythroleukaemia cells represent erythroid precursors blocked near the CFU-E or proerythroblast 
stage. In contrast o their non-leukaemic equivalents, neither their proliferation or their differentiation 
seems to be affected by erythropoietin. However, we show in this paper that both uncommitted and commit- 
ted, benzidine-positive, cells bind iodinated erythropoietin. The binding is of high affinity (& = 490 + 160 
PM) and reversible with a half-life of the complex of 77 f 19 min. The number of binding sites is low (3OG 
600 per cell). In contrast the haematopoietic non-erythroid cell lines HL 60 and L 1210 and the myeloid- 
erythroid human cell line K 562 do not exhibit specific binding. If these binding sites represent true hormone 
receptors, their presence on a permanent cell line should facilitate erythropoietin receptor purification 
Erythropoietin binding; (Murine erythroleukemia cell) 
1. INTRODUCTION 
The study of the mode(s) of action of 
erythropoietin (Epo) has been hampered until 
recently by the lack of pure hormone and by the 
difficulty in isolating homogeneous target cells in 
sufficiently large numbers. Binding of Epo was 
first demonstrated with the help of antibodies [l]. 
Recently, the isolation of the gene of Epo and its 
use in genetic engineering [2] made the pure hor- 
mone available, and techniques were described for 
obtaining erythroid progenitor cells either from 
normal erythropoietic organs [3-51, or after treat- 
ment of mice with the so-called anemic strain of 
the virus complex of Friend [6]. Using the latter 
technique, which induces a transient proliferation 
of erythroid progenitors still dependent on Epo for 
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their differentiation, Krantz and Goldwasser [7] 
described a specific binding of tritiated Epo with 
an apparent equilibrium dissociation constant (Kd) 
of the order of 5.2 nM and a mean number of 600 
receptors per cell. While studying the binding of 
Epo by erythroid progenitors from rat fetal liver 
(forthcoming paper), we observed that ‘ordinary’ 
murine erythroleukaemia cells (MEL, Friend cells) 
were also able to bind Epo specifically. These 
transformed cells are generally considered as being 
erythroid progenitors (probably CFU-E) blocked 
in their differentiation and not responsive to Epo 
but inducible to differentiate by several agents like 
dimethyl sulphoxide or hexamethylene bisacet- 
amide (HMBA) (reviews on Friend cells in [S-lo]). 
This paper presents some characteristics of Epo 
binding by Friend cells. A murine lymphoma 
(L 1210), a human myeloid-erythroid transformed 
cell line (K 562) and a human myelomonocytic 
transformed cell line (HL 60) were also tested for 
Epo binding. 
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2. MATERIALS AND METHODS 
MEL cell lines 745 and 707 (clone 17C) were 
maintained by reseeding every 3-4 days in RPM1 
1640 medium (Gibco, Paisley, Scotland) contain- 
ing 10% (v/v) horse serum. Under these condi- 
tions, the cells proliferated exponentially until they 
reached a density of 3-4 x i06/ml, with a doubling 
time of 12-16 h. Differentiation was induced by 
adding 5 mM HMBA to the cell suspensions at the 
beginning of the exponential growth: 4 days later, 
haemoglobinized benzidine-positive cells [ 1 I] 
represented 85-95% of the population. 
HL 60 and K 562 cell lines were grown in RPM1 
1640 containing 10% (v/v) bovine fetal serum and 
L 1210 cell line was maintained in Eagle-Dulbecco 
medium containing 2.5% (v/v) bovine fetal serum. 
2.2. Erythropoietin 
Pure Epo, produced from isolated human Epo 
gene by Kirin-Amgen, and purchased from Amer- 
sham (Amersham, England) had a specific activity 
of 70000 Ulmg. Its labelled derivative, 
3-[1251]iodotyrosyler~hropoietin, was also pur- 
chased from Amersham; 3 batches were used with 
specific activities at delivery ranging from 730 to 
1200 Ci/mmol. In some experiments pig non- 
radioactive Epo (spec. act. 1010 U/mg protein, 
CNTS Paris) was also used and gave results com- 
pletely superimposable to, and therefore combined 
with, those obtained with the pure human 
hormone. 
2.3. ~eus~re~ent of Epo minding 
Cells (1-8 x 106) were incubated in 100 pl RPM1 
1640 containing lOolo (v/v) heat-inactivated bovine 
fetal serum and graded concentrations of radioac- 
tive Epo. At the end of the incubations, the cells 
were rapidly chilled by addition of 4 ml ice-cold 
RPM1 to each 100/11 sample, and harvested by 
centrifugation (180 x g, 5 min); they were washed 
and harvested 3 more times and finally resuspend- 
ed in 0.5 ml water and their radioactivity measured 
by y counting (~~0 counting efficiency). Non- 
specific binding was the binding observed after in- 
cubations in the presence of concentrations of non- 
labelled Epo at least lo-times (generally 50-times) 
those of the radioactive hormone; total binding 
was the binding observed in the absence of non- 
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labelled hormone and high-affinity (‘specific’) 
binding was the calculated difference total minus 
non-specific binding. 
3. RESULTS 
3.1. Friend cell line 745 
3.1.1. Existence of Epo high-affinity binding 
Fig.1 presents the results obtained after 2 h in- 
cubation at 37°C in the presence of 200 pM 
(26000 cpm) radioactive Epo and in the presence 
or absence of 5 nM non-labelled Epo. Bound 
radioactivities (total, non-specific and specific) 
were proportional to cell density throughout the 
range tested (1-8 x lo6 cells/100 /cl); using 10 nM 
non-labelled Epo instead of 5 nM did not affect 
significantly non-specific binding. High-affinity 
binding was also evident after 3 h incubation at 
2O”C, but not after 5 h incubation at 0°C (not 
shown). 
3.1.2. Kinetics of Epo binding 
As shown in fig.2 Epo high-affinity binding at 
Fig. 1. Binding of l’251)Epo t  murine eryt~roleukaemia 
cells. (m) Total binding (T), (e) non-specific binding 
(NS) and (A) high-affinity (specific) binding (S) were 
determined as described in the text. (0) Non-specific 
binding measured with 10 nM unlabelled Epo (4 x IO6 
cells only). 
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Fig.2. Association and dissociation kinetics of [‘ZSI]Epo 
binding. Results from a typical experiment. 5 x IO6 cells 
were incubated at 37°C with 140 pM [‘*‘I]Epo; 
diss~iation was initiated by adding 5 nM unlabelled 
Epo after 1 h incubation. (Inset) Ratio of specific 
activity remaining associated with the cells @)/activity 
specifically bound by the cells at the beginning of the 
chase (&) was plotted on a logarithmic scale vs time. 
Each point in the mean of 3 independent experiments 
and error bars represent he SD. 
37’% increased during approximately the first 
45 min of incubation and remained stable 
thereafter for at least 4 h. The plateau reflected an 
equilibrium state of reversible binding since the ad- 
dition of non-radioactive Epo after 1 h incubation 
led to a decrease in the specifically bound radioac- 
tivity. Expressing this decrease on a logarithmic 
scale (inset) revealed a first-order dissociation reac- 
tion with a half-life of the complex of 77 f 19 min 
(mean f SD of 3 independent experiments). Never- 
theless, a small fraction (-30%) of the complex 
seemed to dissociate more slowiy (see section 4). 
3.1.3. Characteristics of Epo binding 
The apparent equilibrium dissociation constant 
(&) was evaluated on Scatchard representations of 
high-affinity binding at equilibrium of graded con- 
centrations of labelled Epo (fig.3 shows a typical 
experiment). 3 inde~ndent experiments gave & = 
Fig.3. Binding of [‘*‘I]Epo to differentiated (+) and 
undifferentiated (-) murine erythroleukaemia cells as a 
function of the concentration of [r2’I]Epo added. Cells 
(6 x ld in loO,&) were incubated at 37’C for 2 h with 
various concentrations of (‘2SIfEpo. Scatchard analysis 
of the data. (Inset) Direct representation. 
490 f 160 pM (mean + SD), for non-induced 
Friend cells of the 745 strain and & = 551 f 
168 pM for the same cells after HMBA induction, 
the number of binding sites per cell being 504 f 
160 and 368 Z!Z 129, respectively. At the end of in- 
Table 1 
High-affinity binding of [‘251]Epo to continuous cell 
lines of the haematopoietic lineages 
Cell 
lines 
Biological 
characteristics 
[1251]Epo speci- 
fically bound 
(cpm x 5 x lo6 
cells) 
745 murine erythroleukaemia 1014 * 61 
707 17 C murine er~hroleukaemia 1006&60 
L 1210 murine lymphoma 21 * 29 
K 562 human myeloid-erythroid 43 * 60 
HL60 human myelomonocytic 26 f 22 
Cells in late exponential growth phase were labelled for 
2 h with 200 pM [1251]Epo. Labelling was corrected for 
non-specific binding. Each vaIue is the mean + SD of 6 
d~erminations 
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cubation, the medium was submitted to molecular 
sieve chromatography (Ultrogel AcA 54) or SDS- 
polyacrylamide gel electrophoresis: in both cases, 
no significant alteration of Epo during incubation 
could be detected. 
3.2. Other cell lines 
Friend cells of strain 707 (clone 17 C) also 
bound Epo with high affinity, but not the non- 
erythroid L 1210 and HL 60, or K 562 cell lines 
(table 1). 
4. DISCUSSION 
As indicated by 
Friend cells bound 
the Scatchard plots (fig.3), 
Epo with high affinity at a 
single population of sites; the discontinuity ob- 
served in the curve representing the time course of 
dissociation in chase experiments (inset, fig.3) 
reflects probably a modification of the behaviour 
of the ligand-receptor complexes (internaliza- 
tion?). As Friend cells are not responsive to Epo 
and as we did not test for the specificity of binding, 
we cannot conclude that the high-affinity Epo 
binding sites are hormone receptors but one may 
note that: (i) the number of sites per cell is similar 
to that observed in responsive cells [7], and (ii) 
non-erythroid cells have no binding sites. The ap- 
parent Kd we measured is lo-times smaller than 
that obtained by Krantz and Goldwasser [7]: this 
difference might be due to the fact that these 
authors used a hormone labelled by tritiation of its 
carbohydrate moiety whereas we used a prepara- 
tion iodinated on a tyrosyl residue of the peptide 
backbone. As will be reported in detail elsewhere 
we also measured Epo high-affinity binding on 
erythroid progenitors from rat fetal liver and 
found 500 receptor sites per cell with a & of 
170 pM. By its nature (heavily glycosylated pro- 
tein) and its function, Epo is similar to the colony- 
stimulating factors (CSF) of various haemopoietic 
lines for which a small number of receptors with 
very high affinity (& between 10m9 and lo-” M) 
seems to be the rule (brief review [ 121). Apparently 
the effects of the neoplastic transformation of 
erythroid cells on their Epo binding properties are 
diverse. K 562 cells, which are deeply modified and 
present granulocytic, monocytic and mega- 
caryocytic properties beside erythroid ones [ 131 
and do not respond to Epo [14], have no receptors. 
Friend cells, which also do not respond to Epo but 
exhibit only erythroid potentialities, bind the hor- 
mone with high affinity both before and after in- 
duced differentiation: the small decrease in the 
number of binding sites per cell observed after 
HMBA induction may be related to the decrease in 
cell size. If the binding sites observed on Friend 
cells represent hormone receptors the lack of 
response to Epo may be at the level of signal 
transduction. Epo was recently reported to 
stimulate adenylate cyclase activity of the mem- 
branes of erythroblasts [151: it would be interesting 
to test if the same effect is observed in Friend cells. 
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